What is Oragenics Inc?
, a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 906.90K.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.